THE MCMANUS GROUP for GENENTECH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. S. 2764/H.R.5391 - Protecting Patient Access to Cancer and Complex Therapies Act Issues related to PBM provisions included in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act. H.R.5547/S. 476 - Maintaining Investments in New Innovation Act
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Health Issues HCR
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. Issues related to PBM provisions included in H.R.10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act.
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas |
Taxation/Internal Revenue Code TAX
Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023 H.R.7024 - Tax Relief for American Families and Workers Act of 2024 S.866 - American Innovation and Jobs Act
Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.